CXCR4 and pancreatic adenocarcinoma: In a pancreatic adenocarcinoma slice culture system, the combination of CXCR4 inhibition and PD-1 blockade led to redistribution of CD8+ T cells from the stroma into the tumor, T-cell proliferation, clonal T-cell expansion, and cancer cell death (41).